Is Myo-inositol worth it?
Myo-inositol has a defensible PCOS lane, especially for cycle regularity and modest metabolic or androgen-marker support. It is not a generic insulin-sensitivity hack for everyone and not a replacement for lifestyle, metformin, or fertility care. Buy plain clinical-dose myo-inositol rather than a hormone blend with tiny dustings.
The call
The best evidence is PCOS-specific, not general metabolic optimization. A 2023 systematic review and meta-analysis of randomized trials found inositols improved menstrual-cycle normalization versus placebo and produced small favorable changes in fasting glucose, BMI, and androgen markers, while some insulin-resistance measures did not clearly improve. The 2023 international PCOS guideline is more cautious: inositol can be considered based on patient preference, but clinical benefits are limited and no specific type, dose, or combination can be firmly recommended. That combination earns a mixed keep verdict for PCOS-focused buyers, not a broad blood-sugar verdict for everyone.
Safety
Inositol is generally well tolerated, with possible nausea, gas, diarrhea, headache, dizziness, or fatigue. It may modestly affect glucose markers, so people using insulin or glucose-lowering medication should monitor blood sugar and avoid stacking multiple insulin-sensitizing supplements without guidance. PCOS with infertility, pregnancy, diabetes, abnormal uterine bleeding, or significant endocrine medication use should be clinician-managed rather than self-treated. Avoid high-dose experimentation in children or during breastfeeding unless a clinician specifically recommends it.
Dose that matters: 2 g myo-inositol twice daily, commonly paired with folic acid; many combination products use a 40:1 myo-inositol:D-chiro-inositol ratio, but guideline-level evidence does not establish one best formulation. Reassess symptoms, cycles, and metabolic labs after 8-12 weeks.
Sources
Tier 1 · evidence synthesis · Reviewed by the Stack-kit desk